|
|
Volumn 371, Issue 9623, 2008, Pages 1477-
|
|
NICE and new drugs for rheumatoid arthritis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ATLIZUMAB;
METHOTREXATE;
RITUXIMAB;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
COST EFFECTIVENESS ANALYSIS;
DAILY LIFE ACTIVITY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG MECHANISM;
EDITORIAL;
HEALTH ASSESSMENT QUESTIONNAIRE;
HUMAN;
MEDICAL SOCIETY;
PATIENT CODING;
PRIORITY JOURNAL;
QUALITY ADJUSTED LIFE YEAR;
RHEUMATOID ARTHRITIS;
TREATMENT RESPONSE;
|
|
EID: 43049095388
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(08)60629-7 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|